CX Institutional’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.74M Sell
59,588
-6,686
-10% -$973K 0.25% 92
2026
Q1
$9.57M Sell
66,274
-49,403
-43% -$7.49M 0.29% 76
2025
Q4
$16.6M Buy
115,677
+44,172
+62% +$6.51M 0.49% 45
2025
Q3
$11M Buy
71,505
+3,595
+5% +$561K 0.33% 61
2025
Q2
$10.8M Sell
67,910
-29,240
-30% -$4.77M 0.38% 50
2025
Q1
$16.6M Sell
97,150
-5,751
-6% -$963K 0.63% 38
2024
Q4
$17.3M Buy
102,901
+54,699
+113% +$9.32M 0.69% 36
2024
Q3
$8.35M Buy
48,202
+6,299
+15% +$1.07M 0.37% 72
2024
Q2
$6.91M Sell
41,903
-2,197
-5% -$359K 0.32% 77
2024
Q1
$7.16M Sell
44,100
-14,602
-25% -$2.29M 0.34% 74
2023
Q4
$8.6M Buy
58,702
+1,658
+3% +$246K 0.46% 61
2023
Q3
$8.32M Sell
57,044
-18,906
-25% -$2.89M 0.46% 59
2023
Q2
$11.5M Buy
75,950
+3,036
+4% +$458K 0.6% 47
2023
Q1
$10.9M Buy
72,914
+39,171
+116% +$5.6M 0.58% 39
2022
Q4
$5.11M Buy
33,743
+1,320
+4% +$185K 0.31% 77
2022
Q3
$4.09M Buy
32,423
+20,390
+169% +$2.9M 0.28% 95
2022
Q2
$1.73M Sell
12,033
-793
-6% -$119K 0.13% 190
2022
Q1
$1.96M Sell
12,826
-21,708
-63% -$3.4M 0.16% 153
2021
Q4
$5.65M Sell
34,534
-5,611
-14% -$833K 0.45% 62
2021
Q3
$5.61M Buy
40,145
+1,081
+3% +$153K 0.46% 60
2021
Q2
$5.27M Buy
39,064
+1,410
+4% +$191K 0.43% 60
2021
Q1
$5.1M Buy
37,654
+16,976
+82% +$2.21M 0.46% 57
2020
Q4
$2.88M Buy
20,678
+1,881
+10% +$263K 0.28% 104
2020
Q3
$2.61M Buy
18,797
+3,466
+23% +$460K 0.28% 103
2020
Q2
$1.83M Buy
15,331
+2,021
+15% +$236K 0.24% 116
2020
Q1
$1.46M Buy
13,310
+2,872
+28% +$345K 0.24% 95
2019
Q4
$1.3M Buy
10,438
+295
+3% +$36.1K 0.23% 91
2019
Q3
$1.26M Buy
10,143
+52
+0.5% +$6.14K 0.2% 107
2019
Q2
$1.11M Buy
10,091
+7
+0.1% +$746 0.18% 122
2019
Q1
$1.05M Buy
10,084
+1,339
+15% +$130K 0.19% 127
2018
Q4
$804K Buy
8,745
+8,593
+5,653% +$768K 0.17% 106
2018
Q3
$13K Sell
152
-109
-42% -$8.91K ﹤0.01% 244
2018
Q2
$20K Buy
+261
New +$19.6K 0.01% 192

Other funds holding PG

CX Institutional's PG Position: Q2 2026 in Review

CX Institutional reduced its Procter & Gamble (PG) stake by 10% in Q2 2026, selling an estimated $973K and leaving 59,588 shares worth $8.74M. The position accounts for 0.25% of the portfolio, ranked #92.

CX Institutional first reported a position in PG in Q2 2018 and has held it in 33 quarters since. The position peaked at $17.3M in Q4 2024. 978 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • CX Institutional held 59,588 shares of Procter & Gamble worth $8.74M as of Q2 2026.
  • CX Institutional sold 6,686 Procter & Gamble shares in Q2 2026, an estimated $973K.
  • Procter & Gamble made up 0.25% of CX Institutional's portfolio in Q2 2026, its #92 holding.
  • CX Institutional first reported a position in Procter & Gamble in Q2 2018 and has held it in 33 quarters since.
  • CX Institutional's Procter & Gamble position peaked at $17.3M in Q4 2024.
  • 978 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.